IGC Pharma, Inc.IGCNYSE
Loading
R&D Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+16.2%
5Y CAGR+29.3%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+16.2%/yr
vs +103.1%/yr prior
5Y CAGR
+29.3%/yr
Recent deceleration
Acceleration
-86.9pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
3.6x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$3.65M-3.1%
2024$3.77M+9.0%
2023$3.46M+48.5%
2022$2.33M+150.8%
2021$929000.00-8.1%
2020$1.01M-19.5%
2019$1.26M+816.8%
2018$137000.00+20.2%
2017$114000.00-
2016$0.00-